Boston Scientific Shares Sold by Park Avenue Securities

Institutional investor reduces stake in medical equipment provider

Mar. 24, 2026 at 9:22am

Got story updates? Submit your updates here. ›

Park Avenue Securities LLC lowered its stake in Boston Scientific Corporation (NYSE:BSX) by 61.1% during the fourth quarter, according to a recent SEC filing. The institutional investor owned 20,136 shares of the medical equipment provider's stock after selling 31,595 shares.

Why it matters

This filing provides insight into the trading activity of a major institutional investor in Boston Scientific, a leading medical device company. Changes in institutional ownership can impact a stock's price and trading volume.

The details

According to the SEC filing, Park Avenue Securities LLC sold 31,595 shares of Boston Scientific stock during the fourth quarter. This reduced their total holdings in the company to 20,136 shares, valued at $1.92 million as of the most recent filing.

  • Park Avenue Securities LLC filed the 13F report disclosing the stake reduction in the fourth quarter of 2025.

The players

Park Avenue Securities LLC

An institutional investor that manages assets for clients.

Boston Scientific Corporation

A global medical device company that develops and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing shifts in institutional ownership of Boston Scientific stock, which can impact the stock's trading dynamics. Investors will likely continue to monitor changes in major shareholders' positions for insights into the stock's future performance.